Therapeutic options for newly diagnosed multiple myeloma / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 389-391, 2008.
Article
en Zh
| WPRIM
| ID: wpr-471307
Biblioteca responsable:
WPRO
ABSTRACT
According to the latest classification of International Myeloma Working Group(IMWG),multiple myeloma(MM)is roughly classified into two groups,asymptomatic myeloma(smoldering myeloma)and symptomatic myeloma.The former is equal to the stage Ⅰ of Durie-Salmon(DS),and patients of this type only wait and see,and do not need any therapy.The later is equal to stage Ⅱ and Ⅲ of DS,and patients of this type need therapy immediately.Autologous stem cell transplantation(ASCT)is recommended by National Comprehensive Cancer Network(NCCN)for patients with stage Ⅱ or Ⅲ myeloma with good performance status in 2007.Different therapeutic regiwen should he selected for newly diagnosed MM patients according to whether ASCT is suitable or not.
Texto completo:
1
Bases de datos:
WPRIM
Tipo de estudio:
Diagnostic_studies
Idioma:
Zh
Revista:
Journal of Leukemia & Lymphoma
Año:
2008
Tipo del documento:
Article